Off-Target Lapatinib Activity Sensitizes Colon Cancer Cells Through TRAIL Death Receptor Up-Regulation - http://stm.sciencemag.org/content...
Jun 13, 2011
from
@weldeiry love your new paper in Sci.Trans.Med http://bit.ly/jJgtMM Have their been any studies of lapatinib + capecitabine in CRC?
- Sally Church